BeOne Medicines (ONC) Free Cash Flow (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.25% |
| Dec 31, 2025 | -30.57% |
| Sep 30, 2025 | 53.72% |
| Jun 30, 2025 | 1,768.04% |
| Mar 31, 2025 | -103.93% |
| Dec 31, 2024 | 640.27% |
| Sep 30, 2024 | 126.62% |
| Jun 30, 2024 | 39.19% |
| Mar 31, 2024 | 49.99% |
| Dec 31, 2023 | -1,202.76% |
| Sep 30, 2023 | 112.85% |
| Jun 30, 2023 | 24.03% |
| Mar 31, 2023 | -42.83% |
| Dec 31, 2022 | 34.45% |
| Sep 30, 2022 | -55.85% |
| Jun 30, 2022 | -52.74% |
| Mar 31, 2022 | -226.97% |
| Dec 31, 2021 | 139.42% |
| Sep 30, 2021 | -19.66% |
| Jun 30, 2021 | -599.29% |
| Mar 31, 2021 | 122.48% |
| Dec 31, 2020 | -20.31% |
| Sep 30, 2020 | -28.79% |
| Jun 30, 2020 | 25.62% |
| Mar 31, 2020 | -10.97% |
| Dec 31, 2019 | -26.79% |
| Sep 30, 2019 | -329.14% |
| Jun 30, 2019 | 68.94% |
| Mar 31, 2019 | -14.70% |
| Dec 31, 2018 | 1.31% |
| Sep 30, 2018 | -48.30% |
| Jun 30, 2018 | -1.09% |
| Mar 31, 2018 | -195.98% |
| Dec 31, 2017 | 1,094.77% |
| Sep 30, 2017 | 79.58% |
| Jun 30, 2017 | -54.46% |
| Mar 31, 2017 | 23.13% |
| Dec 31, 2016 | -211.44% |
| Sep 30, 2016 | 35.91% |
| Jun 30, 2016 | -6.77% |
| Mar 31, 2016 | -55.40% |
| Dec 31, 2015 | -26.91% |
| Sep 30, 2015 | -86.42% |
| Jun 30, 2015 | 9.33% |